GP

Govindaraju Parthasarathy

Active Director Director DIN 10378676
DIN 10378676 First appointment Nov 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Govindaraju Parthasarathy

Data last updated:

Govindaraju Parthasarathy is a Director at Vipassu Remedies Private Limited (since 2023).

DIN 10378676
Primary Designation Director
First Appointment 02 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vipassu Remedies Private Limited U47720TS2023PTC178678
Director02 Nov 20232023Active

Board colleagues of Govindaraju Parthasarathy

NameDINCompanyDesignation
Ravi Suman07761283Vipassu Remedies Private LimitedDirector
Vithya10378677Vipassu Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vipassu Remedies Private Limited
Premium access

Shareholding and investment profile for Govindaraju Parthasarathy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Govindaraju Parthasarathy

Govindaraju Parthasarathy currently holds 1 directorship: Vipassu Remedies Private Limited (Director, since 02 Nov 2023).

Govindaraju Parthasarathy was first appointed on 02 Nov 2023 as Director at Vipassu Remedies Private Limited.

The current boards of Govindaraju Parthasarathy's companies include Ravi Suman (Vipassu Remedies Private Limited), Vithya (Vipassu Remedies Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available